Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Jiangsu Kanion Pharmaceutical Co Ltd cash flow reinvestment rate. Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow Reinvestment Rate of 0.64x as of September 2025, reinvesting CN¥128.94 Million (capex CN¥128.94 Million ) from operating cash flow of CN¥201.83 Million. See 600557 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Cash flow reinvestment rate of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. Historical reinvestment intensity for Jiangsu Kanion Pharmaceutical Co Ltd across 23 annual periods. Explore 600557 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2001–2024)
Jiangsu Kanion Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2001 to 2024. Year-by-year capital reinvestment analysis for Jiangsu Kanion Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangsu Kanion Pharmaceutical Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.31x | CN¥919.25 Million | CN¥702.49 Million | CN¥476.69 Million | ▲ +51.9% |
| 2023 | 0.86x | CN¥837.79 Million | CN¥972.32 Million | CN¥297.48 Million | ▲ +269.6% |
| 2022 | 0.23x | CN¥232.16 Million | CN¥995.94 Million | CN¥211.09 Million | ▼ -35.8% |
| 2021 | 0.36x | CN¥330.02 Million | CN¥908.30 Million | CN¥171.52 Million | ▼ -12.1% |
| 2020 | 0.41x | CN¥289.74 Million | CN¥701.10 Million | CN¥190.32 Million | ▼ -22.1% |
| 2019 | 0.53x | CN¥491.24 Million | CN¥925.73 Million | CN¥490.06 Million | ▲ +3.6% |
| 2018 | 0.51x | CN¥325.92 Million | CN¥636.39 Million | CN¥315.73 Million | ▼ -49.5% |
| 2017 | 1.01x | CN¥388.01 Million | CN¥382.93 Million | CN¥260.94 Million | ▼ -10.0% |
| 2016 | 1.13x | CN¥336.59 Million | CN¥299.02 Million | CN¥325.24 Million | ▲ +50.1% |
| 2015 | 0.75x | CN¥386.09 Million | CN¥514.80 Million | CN¥374.80 Million | ▼ -24.5% |
| 2014 | 0.99x | CN¥309.36 Million | CN¥311.54 Million | CN¥309.36 Million | ▲ +13.6% |
| 2013 | 0.87x | CN¥339.23 Million | CN¥388.11 Million | CN¥339.23 Million | ▼ -27.0% |
| 2012 | 1.20x | CN¥253.88 Million | CN¥212.11 Million | CN¥253.88 Million | ▼ -63.2% |
| 2011 | 3.25x | CN¥293.53 Million | CN¥90.19 Million | CN¥293.53 Million | ▲ +90.1% |
| 2010 | 1.71x | CN¥284.89 Million | CN¥166.40 Million | CN¥284.89 Million | ▲ +15.3% |
| 2008 | 1.48x | CN¥86.69 Million | CN¥58.39 Million | CN¥86.69 Million | ▲ +133.8% |
| 2007 | 0.63x | CN¥58.88 Million | CN¥92.73 Million | CN¥58.88 Million | ▲ +182.2% |
| 2006 | 0.22x | CN¥24.52 Million | CN¥108.98 Million | CN¥24.52 Million | ▼ -57.3% |
| 2005 | 0.53x | CN¥53.39 Million | CN¥101.44 Million | CN¥53.39 Million | ▼ -90.7% |
| 2004 | 5.66x | CN¥122.68 Million | CN¥21.68 Million | CN¥122.68 Million | ▼ -23.5% |
| 2003 | 7.40x | CN¥126.72 Million | CN¥17.13 Million | CN¥126.72 Million | ▼ -6.3% |
| 2002 | 7.90x | CN¥88.07 Million | CN¥11.15 Million | CN¥88.07 Million | ▲ +800.5% |
| 2001 | 0.88x | CN¥18.43 Million | CN¥21.02 Million | CN¥18.43 Million | — |